| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 192.06M | 167.49M | 151.60M | 133.16M | 115.13M |
| Gross Profit | 80.05M | 89.64M | 69.62M | 60.53M | 60.63M |
| EBITDA | 115.25M | 101.41M | 106.80M | 76.47M | 81.35M |
| Net Income | 19.29M | 37.98M | 41.34M | 25.33M | 31.00M |
Balance Sheet | |||||
| Total Assets | 700.18M | 683.14M | 668.33M | 658.82M | 674.40M |
| Cash, Cash Equivalents and Short-Term Investments | 27.77M | 40.01M | 8.71M | 12.71M | 8.64M |
| Total Debt | 214.63M | 240.38M | 279.30M | 331.61M | 382.45M |
| Total Liabilities | 277.76M | 300.44M | 338.05M | 371.25M | 411.69M |
| Stockholders Equity | 418.86M | 379.70M | 327.57M | 285.59M | 260.80M |
Cash Flow | |||||
| Free Cash Flow | 50.94M | 94.70M | 81.39M | 76.25M | 29.00M |
| Operating Cash Flow | 76.74M | 103.56M | 94.40M | 82.56M | 40.51M |
| Investing Cash Flow | -25.79M | -8.77M | -12.79M | -6.30M | -11.50M |
| Financing Cash Flow | -63.45M | -63.45M | -85.22M | -72.26M | -24.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £743.67M | 18.63 | 3.49% | 2.22% | -5.70% | ― | |
73 Outperform | £385.45M | 7.75 | 21.84% | 0.38% | 20.92% | 11.45% | |
68 Neutral | £221.22M | 15.39 | 4.61% | ― | 8.82% | -55.40% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
49 Neutral | £17.79M | -34.95 | ― | ― | ― | ― | |
46 Neutral | £3.75M | 118.61 | -12.73% | ― | -88.25% | -905.77% |